Multi-parametric MRI-based radiomics signature for discriminating between clinically significant and insignificant prostate cancer: cross-validation of a machine learning method
ConclusionMp-MRI-based radiomics signature have the potential to noninvasively discriminate between csPCa and ciPCa.
Source: European Journal of Radiology - Category: Radiology Source Type: research
More News: Cancer | Cancer & Oncology | Learning | Pathology | Prostate Cancer | Radiology | Training | Universities & Medical Training